Companion Diagnostic Approaches in the Development of Cell and Gene Therapies

This roundtable focuses on approaches to accelerating your advanced therapy program by leveraging the combination of innovative technology and deep cross-industry insights from our cell and gene therapy scientists and operational leaders. Listen as the panel discuss the adoption of companion diagnostics strategies for your clinical cell and gene therapy development efforts, the evolving landscape of companion diagnostics, the role of anti-AAV neutralizing and total antibody assessment in clinical trials, regulatory considerations for the development of cell and gene therapies and trends with certain regulatory bodies, and considerations for commercializing a companion diagnostics.